BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 19652203)

  • 1. Aurora kinase A is a target of Wnt/beta-catenin involved in multiple myeloma disease progression.
    Dutta-Simmons J; Zhang Y; Gorgun G; Gatt M; Mani M; Hideshima T; Takada K; Carlson NE; Carrasco DE; Tai YT; Raje N; Letai AG; Anderson KC; Carrasco DR
    Blood; 2009 Sep; 114(13):2699-708. PubMed ID: 19652203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional interplay between NF-κB-inducing kinase and c-Abl kinases limits response to Aurora inhibitors in multiple myeloma.
    Mazzera L; Abeltino M; Lombardi G; Cantoni AM; Ria R; Ricca M; Saltarella I; Naponelli V; Rizzi FMA; Perris R; Corradi A; Vacca A; Bonati A; Lunghi P
    Haematologica; 2019 Dec; 104(12):2465-2481. PubMed ID: 30948493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the beta-catenin/TCF transcriptional complex in the treatment of multiple myeloma.
    Sukhdeo K; Mani M; Zhang Y; Dutta J; Yasui H; Rooney MD; Carrasco DE; Zheng M; He H; Tai YT; Mitsiades C; Anderson KC; Carrasco DR
    Proc Natl Acad Sci U S A; 2007 May; 104(18):7516-21. PubMed ID: 17452641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone demethylase JMJD1A promotes colorectal cancer growth and metastasis by enhancing Wnt/β-catenin signaling.
    Peng K; Su G; Ji J; Yang X; Miao M; Mo P; Li M; Xu J; Li W; Yu C
    J Biol Chem; 2018 Jul; 293(27):10606-10619. PubMed ID: 29802196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rab11a sustains GSK3β/Wnt/β-catenin signaling to enhance cancer progression in pancreatic cancer.
    Yu L; Li X; Li H; Chen H; Liu H
    Tumour Biol; 2016 Oct; 37(10):13821-13829. PubMed ID: 27481517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PCDH10 inhibits cell proliferation of multiple myeloma via the negative regulation of the Wnt/β-catenin/BCL-9 signaling pathway.
    Xu Y; Yang Z; Yuan H; Li Z; Li Y; Liu Q; Chen J
    Oncol Rep; 2015 Aug; 34(2):747-54. PubMed ID: 26081897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic inhibition effect of TNIK inhibitor KY-05009 and receptor tyrosine kinase inhibitor dovitinib on IL-6-induced proliferation and Wnt signaling pathway in human multiple myeloma cells.
    Lee Y; Jung JI; Park KY; Kim SA; Kim J
    Oncotarget; 2017 Jun; 8(25):41091-41101. PubMed ID: 28467797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor progression induced by the loss of E-cadherin independent of beta-catenin/Tcf-mediated Wnt signaling.
    Herzig M; Savarese F; Novatchkova M; Semb H; Christofori G
    Oncogene; 2007 Apr; 26(16):2290-8. PubMed ID: 17043652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-744 increases tumorigenicity of pancreatic cancer by activating Wnt/β-catenin pathway.
    Zhou W; Li Y; Gou S; Xiong J; Wu H; Wang C; Yan H; Liu T
    Oncotarget; 2015 Nov; 6(35):37557-69. PubMed ID: 26485754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-1229 overexpression promotes cell proliferation and tumorigenicity and activates Wnt/β-catenin signaling in breast cancer.
    Tan Z; Zheng H; Liu X; Zhang W; Zhu J; Wu G; Cao L; Song J; Wu S; Song L; Li J
    Oncotarget; 2016 Apr; 7(17):24076-87. PubMed ID: 26992223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β-Catenin Inhibitor BC2059 Is Efficacious as Monotherapy or in Combination with Proteasome Inhibitor Bortezomib in Multiple Myeloma.
    Savvidou I; Khong T; Cuddihy A; McLean C; Horrigan S; Spencer A
    Mol Cancer Ther; 2017 Sep; 16(9):1765-1778. PubMed ID: 28500235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PROX1 promotes hepatocellular carcinoma proliferation and sorafenib resistance by enhancing β-catenin expression and nuclear translocation.
    Liu Y; Ye X; Zhang JB; Ouyang H; Shen Z; Wu Y; Wang W; Wu J; Tao S; Yang X; Qiao K; Zhang J; Liu J; Fu Q; Xie Y
    Oncogene; 2015 Oct; 34(44):5524-35. PubMed ID: 25684142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting aurora kinases as therapy in multiple myeloma.
    Shi Y; Reiman T; Li W; Maxwell CA; Sen S; Pilarski L; Daniels TR; Penichet ML; Feldman R; Lichtenstein A
    Blood; 2007 May; 109(9):3915-21. PubMed ID: 17213289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Wnt-beta-catenin signaling in bone metabolism].
    Urano T
    Clin Calcium; 2006 Jan; 16(1):54-60. PubMed ID: 16397351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo.
    Ramachandran I; Thavathiru E; Ramalingam S; Natarajan G; Mills WK; Benbrook DM; Zuna R; Lightfoot S; Reis A; Anant S; Queimado L
    Oncogene; 2012 May; 31(22):2725-37. PubMed ID: 22002305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Aurora kinase A activity enhances the antitumor response of beta-catenin blockade in human adrenocortical cancer cells.
    Maria AG; Silva Borges K; Lira RCP; Hassib Thomé C; Berthon A; Drougat L; Kiseljak-Vassiliades K; Wierman ME; Faucz FR; Faça VM; Tone LG; Stratakis CA
    Mol Cell Endocrinol; 2021 May; 528():111243. PubMed ID: 33716050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TC1(C8orf4) correlates with Wnt/beta-catenin target genes and aggressive biological behavior in gastric cancer.
    Kim B; Koo H; Yang S; Bang S; Jung Y; Kim Y; Kim J; Park J; Moon RT; Song K; Lee I
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3541-8. PubMed ID: 16740781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salt-inducible Kinase (SIK1) regulates HCC progression and WNT/β-catenin activation.
    Qu C; He D; Lu X; Dong L; Zhu Y; Zhao Q; Jiang X; Chang P; Jiang X; Wang L; Zhang Y; Bi L; He J; Peng Y; Su J; Zhang H; Huang H; Li Y; Zhou S; Qu Y; Zhao Y; Zhang Z
    J Hepatol; 2016 May; 64(5):1076-1089. PubMed ID: 26778753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proliferation and bone marrow engraftment of AML blasts is dependent on β-catenin signalling.
    Siapati EK; Papadaki M; Kozaou Z; Rouka E; Michali E; Savvidou I; Gogos D; Kyriakou D; Anagnostopoulos NI; Vassilopoulos G
    Br J Haematol; 2011 Jan; 152(2):164-74. PubMed ID: 21118196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IQGAP1 promotes pancreatic cancer progression and epithelial-mesenchymal transition (EMT) through Wnt/β-catenin signaling.
    Hu W; Wang Z; Zhang S; Lu X; Wu J; Yu K; Ji A; Lu W; Wang Z; Wu J; Jiang C
    Sci Rep; 2019 May; 9(1):7539. PubMed ID: 31101875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.